Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume

Madrigal Pharmaceuticals logo
$513.43 +0.55 (+0.11%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$500.00 -13.43 (-2.62%)
As of 06/23/2026 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Madrigal Pharmaceuticals Short Interest Overview

As of May 29, 2026, Madrigal Pharmaceuticals (MDGL) had a short interest of 3.82 million shares sold short, representing 20.12% of the public float. This marks a -1.91% decrease in short interest since the prior report. The short interest ratio (days to cover) is 14.1, meaning it would take 14.1 days of the average trading volume of 272,441 shares to cover all short positions.

Current Short Interest
3,823,127 shares
Previous Short Interest
3,897,454 shares
Change Vs. Previous Month
-1.91%
Dollar Volume Sold Short
$1.90 billion
Short Interest Ratio
14.1 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
23,060,000 shares
Short Percent of Float
20.12%
Today's Trading Volume
266,384 shares
Average Trading Volume
272,441 shares
Today's Volume Vs. Average
98%
Short Selling Madrigal Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

MDGL Short Interest Over Time

MDGL Days to Cover Over Time

MDGL Percentage of Float Shorted Over Time

Madrigal Pharmaceuticals Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20263,823,127 shares $1.90 billion -1.9%20.1%14.08 $497.27
5/15/20263,897,454 shares $2.04 billion +1.1%20.5%12.33 $523.69
4/30/20263,854,441 shares $1.99 billion -4.0%20.3%16.47 $517.39
4/15/20264,012,756 shares $2.08 billion +2.7%21.1%12.69 $518.58
3/31/20263,909,299 shares $2.05 billion -0.5%21.7%9.12 $523.47
3/13/20263,929,986 shares $1.75 billion +5.0%21.8%13.93 $444.83
2/27/20263,742,574 shares $1.62 billion +3.4%20.8%8.16 $432.00
2/13/20263,619,351 shares $1.68 billion -9.1%19.1%11.08 $464.71
1/30/20263,983,413 shares $1.95 billion +3.2%22.3%12.69 $489.31
1/15/20263,858,573 shares $1.91 billion +4.0%21.6%9.77 $495.88
12/31/20253,710,257 shares $2.16 billion -0.2%20.8%13.07 $582.34
12/15/20253,718,220 shares $2.08 billion -0.1%20.9%14.03 $560.55
11/28/20253,721,183 shares $2.22 billion -1.7%20.9%9.96 $597.05
11/14/20253,786,197 shares $2.00 billion +1.4%21.7%7.38 $529.21
10/31/20253,735,127 shares $1.56 billion +1.3%21.4%12.67 $418.90
10/15/20253,690,000 shares $1.60 billion -0.8%21.2%10.4 $433.45
9/30/20253,720,000 shares $1.71 billion -10.1%N/A9.8 $458.66
9/15/20254,140,000 shares $1.76 billion +2.2%N/A10.9 $425.60
8/31/20254,050,000 shares $1.77 billion +6.9%23.2%10.7 $437.85
8/15/20253,790,000 shares $1.40 billion -4.8%N/A10.2 $369.84
7/31/20253,980,000 shares $1.20 billion +5.0%22.8%11.5 $302.51
7/15/20253,790,000 shares $1.18 billion -4.5%N/A11.2 $311.14
6/30/20253,970,000 shares $1.20 billion -4.3%22.8%11.9 $302.64
6/15/20254,150,000 shares $1.23 billion +6.7%23.8%12.6 $295.57
5/31/20253,890,000 shares $1.08 billion -2.8%23.1%11.6 $276.70
5/15/20254,000,000 shares $1.17 billion -2.4%23.8%10.7 $291.82
4/30/20254,100,000 shares $1.37 billion +1.7%N/A11 $333.91
4/15/20254,030,000 shares $1.29 billion +0.8%23.9%10.7 $321.10
3/31/20254,000,000 shares $1.32 billion -2.2%23.8%9.9 $331.23
3/15/20254,090,000 shares $1.42 billion +9.1%24.3%10.1 $348.35
2/28/20253,750,000 shares $1.28 billion -1.3%22.3%9.3 $341.27
2/15/20253,800,000 shares $1.28 billion -4.5%22.6%9.8 $337.20
1/31/20253,980,000 shares $1.33 billion -2.5%N/A9.9 $334.80
1/15/20254,080,000 shares $1.12 billion -0.7%N/A8.6 $274.41
12/31/20244,110,000 shares $1.27 billion -13.1%N/A9.8 $308.57
12/15/20244,730,000 shares $1.44 billion +10.5%N/A11.2 $304.50
11/30/20244,280,000 shares $1.40 billion -3.4%N/A10.6 $328.19
11/15/20244,430,000 shares $1.28 billion -2.2%N/A11.3 $288.58
10/31/20244,530,000 shares $1.17 billion +11.9%N/A13.1 $259.34
10/15/20244,050,000 shares $875.49 million +4.9%N/A15.1 $216.17
Every time Musk needs a company, he buys it (Ad)

Musk needed batteries - he built the Gigafactory. Needed solar - acquired SolarCity. Needed data - bought Twitter. The pattern is consistent: when a supplier becomes mission-critical, he acquires it. Now, with $75 billion raised in the largest IPO in history, one small power infrastructure company is the critical piece his $2 trillion empire can't run without. Dylan Jovine has the name and ticker.tc pixel

See the stock Musk's acquisition playbook says he needs now
9/30/20243,860,000 shares $819.17 million +3.5%N/A13.8 $212.22
9/15/20243,730,000 shares $901.91 million -0.8%N/A13.5 $241.80
8/31/20243,760,000 shares $929.21 million +0.3%N/A11.5 $247.13
8/15/20243,750,000 shares $916.88 million +1.9%N/A9.5 $244.50
7/31/20243,680,000 shares $1.05 billion -10.5%N/A8.6 $284.66
7/15/20244,110,000 shares $1.15 billion +0.7%N/A9.1 $279.95
6/30/20244,080,000 shares $1.14 billion -7.9%N/A9.1 $280.16
6/15/20244,430,000 shares $1.23 billion -15.3%N/A9.5 $277.59
5/31/20245,230,000 shares $1.24 billion +25.4%N/A9.4 $236.16
5/15/20244,170,000 shares $882.91 million +4.8%N/A8.1 $211.73
4/30/20243,980,000 shares $812.00 million +16.7%N/A6.9 $204.02
4/15/20243,410,000 shares $788.97 million +1.5%N/A5.9 $231.37
3/31/20243,360,000 shares $897.25 million +3.1%N/A6 $267.04
3/15/20243,260,000 shares $881.41 million -5.8%20.2%5.9 $270.37
2/29/20243,460,000 shares $817.25 million +2.1%21.4%7.3 $236.20
2/15/20243,390,000 shares $753.33 million +8.0%21.1%7.6 $222.22
1/31/20243,140,000 shares $680.47 million -5.1%19.5%7.2 $216.71
1/15/20243,310,000 shares $780.50 million +1.9%21.1%8.6 $235.80
12/31/20233,250,000 shares $751.99 million +5.9%20.7%7.9 $231.38
12/15/20233,070,000 shares $727.99 million -11.5%19.5%6.7 $237.13
11/30/20233,470,000 shares $705.45 million +0.3%24.4%7.1 $203.30
11/15/20233,460,000 shares $559.41 million +1.5%24.3%7.7 $161.68
10/31/20233,410,000 shares $448.01 million +13.3%24.7%8.2 $131.38
10/15/20233,010,000 shares $422.51 million +13.6%21.8%7.6 $140.37
9/30/20232,650,000 shares $387.01 million +24.4%19.2%7.4 $146.04
9/15/20232,130,000 shares $374.65 million +8.7%16.5%6.3 $175.89
8/31/20231,960,000 shares $352.80 million +8.3%15.2%6.3 $180.00
8/15/20231,810,000 shares $315.25 million -1.1%14.0%5.7 $174.17
7/31/20231,830,000 shares $375.70 million -3.2%13.8%5.3 $205.30
7/15/20231,890,000 shares $426.71 million +7.4%14.3%5.4 $225.77
6/30/20231,760,000 shares $406.56 million +10.0%13.3%4.7 $231.00
6/15/20231,600,000 shares $408.85 million +10.3%12.1%4.7 $255.53
5/31/20231,450,000 shares $403.69 million +15.1%10.4%3.9 $278.41
5/15/20231,260,000 shares $365.77 million -8.7%9.0%3.1 $290.29
4/30/20231,380,000 shares $430.56 million -6.8%10.0%3.3 $312.00
4/15/20231,480,000 shares $354.89 million +19.4%10.8%3.7 $239.79
3/31/20231,240,000 shares $300.40 million +3.3%9.2%3.1 $242.26
3/15/20231,200,000 shares $286.57 million +16.5%8.7%2.3 $238.81
2/28/20231,030,000 shares $279.14 million +9.2%7.4%1.6 $271.01
2/15/2023942,900 shares $266.14 million 0.0%7.2%1.5 $282.26
1/31/2023943,300 shares $271.91 million -3.3%7.2%1.6 $288.25
1/15/2023975,300 shares $292.57 million -12.9%7.5%1.6 $299.98
12/30/20221,120,000 shares $325.08 million -52.7%9.0%1.9 $290.25
12/15/20222,370,000 shares $149.07 million +9.7%19.1%4.3 $62.90
11/30/20222,160,000 shares $151.44 million +3.9%17.4%7.3 $70.11
11/15/20222,080,000 shares $146.68 million +14.3%16.8%7.9 $70.52
10/31/20221,820,000 shares $128.89 million +17.4%14.7%7.4 $70.82
10/15/20221,550,000 shares $100.27 million +1.3%12.5%6.6 $64.69
9/30/20221,530,000 shares $99.43 million +2.7%12.4%7.2 $64.99
9/15/20221,490,000 shares $103.70 million +1.4%12.1%7.4 $69.60
Now that SpaceX is public, buy this ticker (no, not SpaceX or Tesla) (Ad)

The SpaceX IPO wasn't the big trade - according to Larry Benedict, founder of The Opportunistic Trader, it was the trigger. Benedict, who delivered a 279% return on cash in 2025 across a 20-year winning streak, says the listing launched what he calls the 'Final Phase of Elon's Master Plan.' He's identified one specific ticker - not SpaceX, Tesla, or any Elon-affiliated company - that he believes could see billions in inflows as this phase unfolds. He calls it his trade of the year.tc pixel

Watch the video now to get the ticker name and full trade details
8/31/20221,470,000 shares $106.02 million -4.6%11.9%7.8 $72.12
8/15/20221,540,000 shares $118.13 million -3.8%12.5%8.6 $76.71
7/31/20221,600,000 shares $100.51 million +3.2%12.9%8.4 $62.82
7/15/20221,550,000 shares $107.24 million -4.3%12.5%8.1 $69.19
6/30/20221,620,000 shares $115.96 million -2.4%13.1%8.1 $71.58
6/15/20221,660,000 shares $112.71 million +3.8%13.4%8.6 $67.90
5/31/20221,600,000 shares $106.22 million -5.3%12.9%8.5 $66.39
5/15/20221,690,000 shares $111.08 million -2.9%13.6%8.8 $65.73
4/30/20221,740,000 shares $121.80 million +1.8%14.0%8.2 $70.00
4/15/20221,710,000 shares $135.89 million -5.5%13.8%7.3 $79.47
3/31/20221,810,000 shares $177.60 million -9.1%14.6%7.8 $98.12
3/15/20221,990,000 shares $179.10 million +0.5%16.0%8.5 $90.00
2/28/20221,980,000 shares $183.84 million -1.5%16.0%8.1 $92.85
2/15/20222,010,000 shares $180.72 million +12.3%16.2%8.4 $89.91
1/31/20221,790,000 shares $103.07 million +19.3%14.4%8.5 $57.58
1/15/20221,500,000 shares $117.68 million +8.7%12.1%9.4 $78.45
12/31/20211,380,000 shares $116.94 million -6.8%11.1%9.6 $84.74
12/15/20211,480,000 shares $110.82 million +7.3%11.9%10.8 $74.88
11/30/20211,380,000 shares $114.14 million +2.2%12.0%12 $82.71
11/15/20211,350,000 shares $122.00 million -3.6%11.8%12.7 $90.37
10/29/20211,400,000 shares $108.85 million +3.7%12.2%13.3 $77.75
10/15/20211,350,000 shares $116.33 million -6.9%12.1%13.5 $86.17
9/30/20211,450,000 shares $115.70 million No Change13.0%14.1 $79.79
9/15/20211,450,000 shares $115.10 million -7.1%13.0%11.9 $79.38
8/31/20211,560,000 shares $129.09 million -5.5%14.0%12.2 $82.75
8/13/20211,650,000 shares $140.02 million +3.1%14.8%10.9 $84.86
7/30/20211,600,000 shares $139.71 million -4.2%14.4%10.4 $87.32
7/15/20211,670,000 shares $157.95 million No Change15.0%11 $94.58
6/30/20211,670,000 shares $162.67 million -5.1%15.0%10.9 $97.41

MDGL Short Interest - Frequently Asked Questions

Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 3,823,127 shares of MDGL short. 20.12% of Madrigal Pharmaceuticals' shares are currently sold short. Learn More on Madrigal Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 14.1. Learn More on Madrigal Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.12% of Madrigal Pharmaceuticals' floating shares are currently sold short.

Madrigal Pharmaceuticals saw a decline in short interest during the month of May. As of May 29th, there was short interest totaling 3,823,127 shares, a decline of 1.9% from the previous total of 3,897,454 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

20.12% of Madrigal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Madrigal Pharmaceuticals: Alnylam Pharmaceuticals, Inc. (4.00%), Biogen Inc. (3.24%), United Therapeutics Corporation (5.65%), Incyte Corporation (6.81%), Neurocrine Biosciences, Inc. (5.76%), Exelixis, Inc. (12.13%), Ionis Pharmaceuticals, Inc. (10.47%), BioMarin Pharmaceutical Inc. (6.06%), Halozyme Therapeutics, Inc. (11.80%), Alkermes plc (10.91%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading up $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MDGL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:MDGL) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners